Programme

MIMS Learning Live will bring you a packed programme of CPD learning on clinical topics relevant to your GP practice.
 
Our 2 streams, Clinical Challenges and Chronic Conditions, will provide practical learning points for you to take back to your daily practice. Each stream will be chaired by an experienced GP, featuring experts who are passionate about their topics.
 

Chronic Conditions and Comorbidity

9:45 | TBC

10:30 | Sponsored Session - Respiratory

More details coming soon

Coffee break and networking

11:45 | Clinical use of GLP-1 RAs (Glucagon-like peptide-1 receptor agonists) in
adults living with Type 2 Diabetes.

  • Recognising the importance of a pro-active holistic approach to management of Type 2 Diabetes
  • Exploring the clinical use of GLP-1 RAs in adults with Type 2 Diabetes
  • Providing practical guidance on the initiation and monitoring of a GLP-1 RA

Dr Amir Ghanghro MBBS MRCGP DCH PGC – GP Partner, St David’s Court Surgery

Novo Nordisk products will be discussed. Prescribing and Adverse Event reporting information will be available at the meeting.

Job Bag ID: UK22DI00318 Date of Prep: Sep 2022

12:30 | Quality Improvement Challenge

A GP-led challenge session enabling better patient care. This session will enable delegates to develop a quality improvement idea for their practice that they can take back and apply straight away. Delegates will discuss their ideas with colleagues, get inspiration from what others have done, and receive a list of QI ideas from the workshops post-event.

Dr Raj Thakker – GP, Primary Care Cardiology Lead, National Primary Care workstream co-lead for CPIP

Lunch break and networking

14:15 | Acne: Update on management

Dr Aysha Javed – Consultant Dermatologist, Countess of Chester Hospital NHS Foundation Trust

Sponsored by L’oreal

15:00 | AstraZeneca - TBC

This is a promotional symposium sponsored and organised by AstraZeneca 

Coffee break and networking

16:15 | Women's health - Pelvic organ prolapse

  • Risk factors and types
  • Symptoms and signs
  • Management options

 

Dr Mageed Abdelrahman – Consultant in urogynaecology at Liverpool Women’s Hospital

Clinical Challenges

9:15 | Guideline update: type 2 diabetes

  • Guidelines and new therapies

  • Cases to challenge you

  • Key take-home messages for GPs

10:00 | The role of a primary care practitioner in ensuring patients with a cancer diagnosis are managed appropriately in the prehabilitation phase

  • To understand Prehabilitation and the evidence to show its impact in Oncology
  • To explore the role of the primary care practitioner in supporting Oncology patients
  • Providing practical guidance to ensure that patients diagnosed with cancer can maximise their strength and resilience before the initiation of treatment.

Dr Rebecca Leon GP Partner, The Middlewood Partnership

This session is sponsored by Nutricia

Coffee break and networking

11:15 | Early diagnosis - Target Ovarian Cancer

GP Dr Victoria Barber discusses how to spot the early signs and symptoms of ovarian cancer, red flags, diagnostic testing, referral, and why you should never diagnose a woman >50 with new IBS.

12:00 | Session TBC

Lunch and networking

13:15 | Quality Improvement Challenge

A GP-led challenge session enabling better patient care – This session will enable delegates to develop a quality improvement idea for their practice that they can take back and apply straight away. Delegates will discuss their ideas with colleagues, get inspiration from what others have done, and receive a list of QI ideas from the workshops post-event.

Dr Raj Thakker – GP, Primary Care Cardiology Lead, National Primary Care workstream co-lead for CPIP

14:30 | UTIs and urinary incontinence in women

  • Diagnosis of urinary tract infections
  • Management options and when to refer
  • Urinary incontinence: urge and stress incontinence
  • Primary care management and referral

Mr Mageed Abdelrahman – consultant in urogynaecology at Liverpool Women’s Hospital

Coffee break and networking

15:45 | Mental health and wellbeing

AstraZeneca has provided a sponsorship grant towards this independent Programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations.